Page last updated: 2024-08-23

bromocriptine and dimethylaminomicheliolide

bromocriptine has been researched along with dimethylaminomicheliolide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, X; Cong, Z; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J	1

Other Studies

1 other study(ies) available for bromocriptine and dimethylaminomicheliolide

Article	Year
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways. Endocrine-related cancer, 2021, 12-13, Volume: 29, Issue:2 Topics: AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Drug Synergism; Early Growth Response Protein 1; Furans; Humans; Pituitary Neoplasms; Prolactinoma; TOR Serine-Threonine Kinases	2021

Article

Year

ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways.

Endocrine-related cancer, 2021, 12-13, Volume: 29, Issue:2

Topics: AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Drug Synergism; Early Growth Response Protein 1; Furans; Humans; Pituitary Neoplasms; Prolactinoma; TOR Serine-Threonine Kinases

2021